Literature DB >> 21705027

Cerebral basis of visual hallucinations in Parkinson's disease: structural and functional MRI studies.

Naroa Ibarretxe-Bilbao1, Carme Junque, Maria J Marti, Eduardo Tolosa.   

Abstract

The presence of visual hallucinations (VH) is a significant predictor of dementia in Parkinson's disease (PD) and it is associated with a more rapid cognitive decline. Non-demented PD patients with VH present greater neuropsychological impairment than those without VH in domains such as verbal and visual memory, language comprehension, and visuospatial and visuoperceptive functions. Frontal dysfunction has also been described in PD with VH, including deficits in verbal fluency, sustained attention, and inhibition. In PD with VH, structural and functional abnormalities within the primary visual system and visual association areas, including ventral and dorsal pathways, have been reported. Structural MRI studies have shown that non-demented PD patients with VH present grey matter reduction in parieto-occipital areas and the hippocampal head. A follow-up study performed at a mean of 30 months revealed that unlike PD patients without VH, PD patients with VH frequently develop dementia associated with progressive atrophy in limbic, paralimbic and neocortical areas. Functional MRI (fMRI) studies have revealed altered activation in occipito-temporal and frontal areas in response to simple and complex visual stimuli in PD patients with VH, suggesting a marked impairment in bottom-up visual processing, as well as an attentional deficit in the pathophysiology of VH in PD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705027     DOI: 10.1016/j.jns.2011.06.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease.

Authors:  James M Shine; Glenda M Halliday; Moran Gilat; Elie Matar; Samuel J Bolitho; Maria Carlos; Sharon L Naismith; Simon J G Lewis
Journal:  Hum Brain Mapp       Date:  2013-06-13       Impact factor: 5.038

2.  Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson's disease and visual hallucinations.

Authors:  James M Shine; Rebecca Keogh; Claire O'Callaghan; Alana J Muller; Simon J G Lewis; Joel Pearson
Journal:  Proc Biol Sci       Date:  2015-01-07       Impact factor: 5.349

3.  Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.

Authors:  M Ferrari; C Comi; F Marino; L Magistrelli; F De Marchi; R Cantello; G Riboldazzi; G Bono; M Cosentino
Journal:  Eur J Clin Pharmacol       Date:  2016-08-06       Impact factor: 2.953

Review 4.  A review of the use of magnetic resonance imaging in Parkinson's disease.

Authors:  Nadya Pyatigorskaya; Cécile Gallea; Daniel Garcia-Lorenzo; Marie Vidailhet; Stéphane Lehericy
Journal:  Ther Adv Neurol Disord       Date:  2014-07       Impact factor: 6.570

5.  Functional Connectivity Differences of the Subthalamic Nucleus Related to Parkinson's Disease.

Authors:  Christian Mathys; Julian Caspers; Robert Langner; Martin Südmeyer; Christian Grefkes; Kathrin Reetz; Alexia-Sabine Moldovan; Jochen Michely; Julia Heller; Claudia R Eickhoff; Bernd Turowski; Alfons Schnitzler; Felix Hoffstaedter; Simon B Eickhoff
Journal:  Hum Brain Mapp       Date:  2015-12-24       Impact factor: 5.038

6.  Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.

Authors:  Dominic H Ffytche; Joana B Pereira; Clive Ballard; K Ray Chaudhuri; Daniel Weintraub; Dag Aarsland
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-04       Impact factor: 10.154

Review 7.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

8.  Increasing Contrast Improves Object Perception in Parkinson's Disease with Visual Hallucinations.

Authors:  Mirella Díaz-Santos; Zachary A Monge; Robert D Salazar; Grover C Gilmore; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Mov Disord Clin Pract       Date:  2020-11-17

9.  Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease.

Authors:  Kyan Younes; Julio C Rojas; Amy Wolf; Goh M Sheng-Yang; Matteo Paoletti; Gianina Toller; Eduardo Caverzasi; Maria Luisa Mandelli; Ignacio Illán-Gala; Joel H Kramer; Yann Cobigo; Bruce L Miller; Howard J Rosen; Michael D Geschwind
Journal:  Ann Clin Transl Neurol       Date:  2021-05-05       Impact factor: 4.511

10.  Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects.

Authors:  Anne Marie Bonnet; Marie France Jutras; Virginie Czernecki; Jean Christophe Corvol; Marie Vidailhet
Journal:  Parkinsons Dis       Date:  2012-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.